Group Leader
Anthony J Gill AM is Professor of Surgical Pathology at the University of Sydney and a senior staff specialist in anatomical pathology at the Royal North Shore Hospital. Anthony has a keen interest in the application of innovative diagnostic pathology techniques in translational cancer research with particular emphasis on cancer biomarker discovery and validation.
He has published extensively in hereditary cancer syndromes as well as endocrine,
gastrointestinal and hepatobiliary pathology, and is an internationally recognised expert on hereditary cancers which arise due to defects in oxidative respiration (so called “SDH deficient” neoplasms).
Anthony is a Chief Investigator of the Cancer Institute NSW Translational Programme Grant which aims to translate 'liquid biopsies' into routien clinical care for cancer diagnosis, screening, monitoring, and treatment. He is also the current chairman and a founding member of the Australian Pancreatic Cancer Genome Initiative based at the Garvan Institute.
In addition to over 700 original publications, Anthony was a standing member of the Editorial Board for the 5th edition of the WHO blue book series (2018-2023). He is currently a member of the expert editorial board for the sixth edition classification system of both gastrointestinal and urological malignancies.
He has received numerous awards from national and international bodies including the Benjamin Castleman Award (2011) and the Ramzi Cotran Young Investigator Award (2017) from the United States and Canadian Academy of Pathology (USCAP), the Sir John Lowenthal Medal (2011) and the Sir Zelman Cowen Universities Prize for discovery in Medical Research from the University of Sydney, the NSW Premier's Award for Excellence in Translational Research (2013) and the NSW Premier's Award for Outstanding Cancer Researcher of the Year (2023) from the Cancer Institute NSW, and the Vincent McGovern Lecture (2017) and the Distinguisned Pathologist Award (2021) from the International Academy of Pathology (IAP). He is a three time recipient of the NSW Cancer Institute Wildfire Award for the most highly cited original research in cancer (2013, 2018, 2019). In 2018 he was appointed a member of the order of Australia (AM) in the Queens Birthday honours list for significant service to medical research in the field of surgical pathology as an academic, author; adviser, and mentor.
Group Members
Adele Clarkson is a senior scientist with over 30 years of experience in diagnostic immunohistochemical analytical techniques. She runs a busy diagnostic immunohistochemistry laboratory at Pathology North, Royal North Shore Hospital, a tertiary level healthcare facility which provides diagnostic services for the management of complex malignancies including haemotolymphoid and solid organ neoplasms. Adele has expertise in the optimisation of novel antibodies for research and diagnostic immunohistochemistry on formalin fixed paraffin embedded (FFPE) tissue.
Loretta Sioson uses the Veridiam tissue arrayer to create tissue micro-arrays containing 1mm diameter cores. She works with diverse tissue types, including colon, brain, thyroid, breast and lung.
Angela Chou is a fellow of the Royal College of Pathologists of Australasia. She divides her time between a busy clinical practice at the Royal North Shore Hospital in Sydney and research work at the University of Sydney where she is Associate Professor. Angela's research interest lies in the translational application of molecular techniques in cancer diagnosis. She is also affiliated with the Australian Pancreatic Cancer Genome Initiative providing specialist input in hepatobiliary and upper gastrointestinal pathology.